4.1 Article

Promoter Variant of PIK3C3 Is Associated with Autoimmunity against Ro and Sm Epitopes in African-American Lupus Patients

Journal

Publisher

HINDAWI LTD
DOI: 10.1155/2010/826434

Keywords

-

Funding

  1. Genentech
  2. T. B. Niewold
  3. NIH [K08 AI083790]
  4. NIAID [AI071651]
  5. NIH CTSA
  6. CTSA [UL1 RR024999]
  7. Lupus Research Institute
  8. Alliance for Lupus Research Target Identification in Lupus Grant
  9. Arthritis National Research Foundation
  10. NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI083790] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The PIK3C3 locus was implicated in case-case genome-wide association study of systemic lupus erythematosus (SLE) which we had performed to detect genes associated with autoantibodies and serum interferon-alpha (IFN-alpha). Herein, we examine a PIK3C3 promoter variant (rs3813065/-442 C/T) in an independent multiancestral cohort of 478 SLE cases and 522 controls. rs3813065 C was strongly associated with the simultaneous presence of both anti-Ro and anti-Sm antibodies in African-American patients [OR - 2.24 (1.34-3.73), P - 2.0 x 10(-3)]. This autoantibody profile was associated with higher serum IFN-alpha (P - 7.6 x 10(-6)). In the HapMap Yoruba population, rs3813065 was associated with differential expression of ERAP2 (P = 2.0 x 10(-5)), which encodes an enzyme involved in MHC class I peptide processing. Thus, rs3813065 C is associated with a particular autoantibody profile and altered expression of an MHC peptide processing enzyme, suggesting that this variant modulates serologic autoimmunity in African-American SLE patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available